The Results of Transcatheter Occlusion of Patent Ductus Arteriosus: Success Rate and Complications Over 12 Years in a Single Center.
10.4070/kcj.2010.40.5.230
- Author:
Deok Young CHOI
1
;
Na Yeon KIM
;
Mi Jin JUNG
;
Seong Ho KIM
Author Information
1. Department of Pediatric Cardiology, Gachon University of Medicine and Science, Incheon, Korea. sarahjk1@gilhospital.com
- Publication Type:Original Article
- Keywords:
Ductus arteriosus, patent
- MeSH:
Arrhythmias, Cardiac;
Body Weight;
Ductus Arteriosus, Patent;
Follow-Up Studies;
Humans;
Insurance, Health;
Pulmonary Artery;
Retrospective Studies
- From:Korean Circulation Journal
2010;40(5):230-234
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND AND OBJECTIVES: Percutaneous occlusion of patent ductus arteriosus (PDA) has become increasingly attractive with the evolution of devices and techniques. We reviewed results for percutaneous occlusion of PDA using various devices in a single center. SUBJECTS AND METHODS: A retrospective review was done for 118 consecutive procedures performed in 111 patients with PDA between January 1996 and December 2007. RESULTS: The median age of the patients was 4.5 years (0.9 to 60.3 years); body weight was 16.9 kg (6.8 to 74.7 kg). The median PDA diameter at the pulmonic end was 3.8 mm (0.7 to 10 mm); mean pulmonary artery pressure was 21.0 mmHg (7 to 60 mmHg). Complete occlusion occurred in 76/111 (68.4%) immediately after implantation and in 100/111 (90.0%) at one year of follow-up. Second procedures for residual shunts were done in 7 patients. After the year 2001, the complete closure rate was 95.2% compared to 71.4% before 2001. Complications associated with the procedure were left pulmonary artery narrowing (all <20 mmHg) in 14, arrhythmia in 2, and death in 1. CONCLUSION: Evolution of devices, cumulative experience, and health insurance covering the cost of devices have contributed to good outcomes in our center for percutaneous occlusion of PDA. Our results have improved over the years, particularly with the use of the Amplatzer duct occluder.